Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EFRAIM II: Steroids and Antifungals for ARF in Immunocompromised Patients
NCT04680884Phase 3Unknown
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Dec 2020
- Primary completion
- Sep 2023
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of methylprednisolone injection, isavuconazole in acute respiratory failure (ARF), sponsored by Assistance publique - Hôpitaux de Paris. Status: unknown.
02
Drugs
methylprednisolone injectionisavuconazole
03
Conditions
acute respiratory failure (ARF)
Beyond the preview
Go deeper on NCT04680884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04680884.